Home/Filings/4/0001214659-23-001042
4//SEC Filing

Meek David D. 4

Accession 0001214659-23-001042

CIK 0001576263other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 4:00 PM ET

Size

7.1 KB

Accession

0001214659-23-001042

Insider Transaction Report

Form 4
Period: 2023-01-20
Meek David D.
DirectorChief Executive Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-01-20+151,233151,233 total
    Exercise: $45.66Exp: 2033-01-20Common Stock (151,233 underlying)
  • Award

    Common Stock

    2023-01-20+89,379151,171 total
Footnotes (2)
  • [F1]Grant of Restricted Stock Units (RSUs). Shares will vest 25% annually on the anniversary of the grant date until fully vested.
  • [F2]25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

Entity typeother

Related Parties

1
  • filerCIK 0001555337

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:00 PM ET
Size
7.1 KB